Adam Quattlebaum
Partner (CPA)
Greenville, SC
Industry Focus
  • Construction
  • Manufacturing & Distribution
More
Service Areas
  • Research & Development Tax Credits
More

Overview

Adam has experience serving publicly traded and closely held companies in the manufacturing, construction, government contracting, and technology industries. Adam's focus is on federal tax specialty services and he leads the firm’s Research & Development tax credits practice. Adam has extensive experience defending and successfully sustaining R&D tax credits through IRS and state audits.

Experience


Professional Organizations
  • American Institute of Certified Public Accountants
  • North Carolina Association of Certified Public Accountants
  • South Carolina Association of Certified Public Accountants
  • PULSE
  • Opportunity Greenville
Education
  • Masters, Accounting
    University of South Carolina
  • Bachelors, Accounting
    University of South Carolina

In the Community


Civic Organizations
  • United Way of Greenville County, Loaned Executive
  • Moore School of Business Young Alumni Board
  • United Way of Greenville County Corporate Solicitor

Honors

  • Greenville Business Journal Best & Brightest Under 35

Licenses

Licenses
  • Certified Public Accountant - NC - 35780
  • Certified Public Accountant - SC - 9102

Knowledge Share

Weathering the Pandemic with R&D and Orphan Drug Tax Credits
Publication | Jul 20, 2020
More About | Technology & Life Sciences | Federal Corporate Tax | Research & Development Tax Credits | Innovation & Technology | Performance & Growth | COVID-19

With the constant discussions surrounding how to weather the COVID-19 storm, more technology and life sciences companies should be evaluating their ability to take advantage of the Credit for Increasing Research Activities (R&D tax credit) to potentially realize substantial cash tax savings. In addition, many life sciences companies that are focused on developing products in accordance with the Orphan Drug designation may be able to take advantage of the Orphan Drug Credit (ODC).

Read More
R & D Tax Credit Enhanced by Virginia and Federal Legislation
Alert | Jul 07, 2016
More About | Tysons, VA

Virginia legislative enhancements provided by the 2016 Virginia General Assembly session to the state research and development tax credits, coupled with expansions of the federal credit provided by the PATH Act (Protecting Americans from Tax Hikes Act of 2015) in late 2015 give Virginia taxpayers extra incentive to pursue Research and Development Tax Credits.

Read More